The Influence of Irinotecan on CD47/PDL-1/GD-2 Expression in Neuroblastoma Cells
Tom Lapidus | Goldyne Savad Institute of Gene and Cell Therapy, Hadassah Hebrew University Hospital, Jerusalem, Israel
Tom Lapidus | Goldyne Savad Institute of Gene and Cell Therapy, Hadassah Hebrew University Hospital, Jerusalem, Israel
Esther Berko | Rina Zaizov Division of Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petach-Tiqva, Israel | Division
Liron Grossmann | Pediatric Hemato-Oncology Division, Sheba Medical Center, Ramat Gan, Israel
Daniel Morgenstern | Solid Tumor Section, Hematology Oncology, Hospital for Sick Children, Toronto, Canada
Sponsored by Takeda Chairs: Shifra Ash, Israel Dalia Waldman, Israel
Mahdi Asleh | Pediatric Hematology Oncology, Soroka University Medical Center, Beer Sheva| Faculty of Medicine, Ben-Gurion University of the Negev,
Asaf Yanir | BMT, Cell Processing Facility, Schneider Children's Medical Center of Israel, Petach-Tiqva, Israel
Noa Greenberg-Kushnir | Pediatric Hemato-Oncology Division, Sheba Medical Center, Ramat Gan, Israel
Orna Steinberg Shemer | Rina Zaizov Division of Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petach-Tiqva, Israel
Alan J. Warren | Hematology Dept., School of Clinical Medicine, University of Cambridge, UK
נותנות החסות לאיגוד: